- US12616710utility2026Topical Compositions0 cites
- US12611378utility2026Targeted Release Rifaximin Compositions0 cites
- US12146003utility2024Ultra-pure Agonists of Guanylate Cyclase C, Method of Making and Using Same0 cites
- US12138278utility2024Topical Compositions0 cites
- US12133859utility2024Topical Compositions0 cites
- US12128059utility2024Topical Compositions0 cites
- US12128137utility2024Topical Compositions and Methods for Treating Skin Diseases0 cites
- US12076404utility2024Stabilized Efinaconazole Compositions as Antifungals0 cites
- US12076403utility2024Pharmaceutical Formulations Containing Corticosteroids for Topical Administration0 cites
- US11986527utility2024Pharmaceutical Formulations Containing Corticosteroids for Topical Administration0 cites
- US11957753utility2024Pharmaceutical Formulations Containing Corticosteroids for Topical Administration0 cites
- US11872218utility2024Compositions and Methods for Treating Diseases of the Nail0 cites
- US11839656utility2023Pharmaceutical Formulations Containing Corticosteroids for Topical Administration0 cites
- US11834521utility2023Ultra-pure Agonists of Guanylate Cyclase C, Method of Making and Using Same0 cites
- US11679115utility2023Topical Compositions and Methods for Treating Psoriasis0 cites
- US11679116utility2023Topical Compositions and Methods for Treating Psoriasis0 cites
- US11654139utility2023Anti-infective Methods, Compositions, and Devices0 cites
- US11648256utility2023Topical Compositions and Methods for Treating Psoriasis0 cites